Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sargent

Showing results (331-340 of 433) with videos related to

Pageof 44
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130James A Martenson, Christopher G Willett, Daniel J Sargent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology GroupsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance)Harry H Yoon, David Tougeron, Qian Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials ProgramChristopher H Lieu, Lindsay A Renfro, Aimery de Gramont, et al.
Journal of Clinical Pathology|May 26, 2010
Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodesJean-François Haince, Michel Houde, Guillaume Beaudry, et al.
Clinical and Translational Science|October 7, 2020
The Translational Approaches to Personalized Health Collaborative: Pharmacogenomics for African American Older AdultsLana J Sargent, Marissa Mackiewicz, Youssef Roman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I studyS R Alberts, P M Townley, R M Goldberg, et al.
Frontiers in Plant Science|August 6, 2019
Identifying <i>Verticillium dahliae</i> Resistance in Strawberry Through Disease Screening of Multiple Populations and Image Based PhenotypingHelen M Cockerton, Bo Li, Robert J Vickerstaff, et al.
Gastroenterology|September 6, 2006
Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patientsFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
Pageof 44

Showing results (331-340 of 433) with videos related to

Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130James A Martenson, Christopher G Willett, Daniel J Sargent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology GroupsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance)Harry H Yoon, David Tougeron, Qian Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials ProgramChristopher H Lieu, Lindsay A Renfro, Aimery de Gramont, et al.
Journal of Clinical Pathology|May 26, 2010
Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodesJean-François Haince, Michel Houde, Guillaume Beaudry, et al.
Clinical and Translational Science|October 7, 2020
The Translational Approaches to Personalized Health Collaborative: Pharmacogenomics for African American Older AdultsLana J Sargent, Marissa Mackiewicz, Youssef Roman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I studyS R Alberts, P M Townley, R M Goldberg, et al.
Frontiers in Plant Science|August 6, 2019
Identifying <i>Verticillium dahliae</i> Resistance in Strawberry Through Disease Screening of Multiple Populations and Image Based PhenotypingHelen M Cockerton, Bo Li, Robert J Vickerstaff, et al.
Gastroenterology|September 6, 2006
Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patientsFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
Pageof 44